Clinical Therapeutics/New Technology-Insulins

Clinical Therapeutics/New Technology-Insulins

You have access
Use of Premixed Insulin, Metformin, and a Glucagon-Like Peptide 1 Receptor Agonist as a Therapeutic Approach for Uncontrolled Type 2 Diabetes
Nicole Ehrhardt, Sasan Fazeli, Sanjana Rao, Richard Amdur

Diabetes Spectrum Mar 2020, ds190025; DOI: 10.2337/ds19-0025
You have access
A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (Onset 9)
Wendy S. Lane, Elena Favaro, Naveen Rathor, Hak C. Jang, Maiken I.S. Kjærsgaard, Alejandra Oviedo, Ludger Rose, Peter Senior, Giorgio Sesti, Alfonso Soto Gonzalez, Edward Franek

Diabetes Care Mar 2020, dc192232; DOI: 10.2337/dc19-2232
Open Access
A Tribute to Robert Roy Henry—The Classic “Academic Triple Threat”: Accomplished Researcher, Inspiring Teacher, and Compassionate Clinician
Steven Edelman, Jerrold Olefsky, Sunder Mudaliar, Ted Ciaraldi, Alain Baron

Diabetes Care Mar 2020, 43 (3) 522-525; DOI: 10.2337/dci19-0075
You have access
A Behavioral Perspective of Therapeutic Inertia: A Look at the Transition to Insulin Therapy
Susan J. Guzman

Diabetes Spectrum Feb 2020, 33 (1) 38-43; DOI: 10.2337/ds19-0024
You have access
Treatment Patterns, Adherence, and Persistence Associated With Human Regular U-500 Insulin: A Real-World Evidence Study
Jieling Chen, Christi Y. Kao, Xuanyao He, Ludi Fan, Jeffrey A. Jackson, Rattan Juneja

Diabetes Spectrum Mar 2020, ds190060; DOI: 10.2337/ds19-0060
Open Access
Baseline Characteristics of Randomized Participants in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
Deborah J. Wexler, Heidi Krause-Steinrauf, Jill P. Crandall, Hermes J. Florez, Sophia H. Hox, Alexander Kuhn, Ajay Sood, Chantal Underkofler, Vanita R. Aroda, the GRADE Research Group

Diabetes Care Nov 2019, 42 (11) 2098-2107; DOI: 10.2337/dc19-0901
You have access
Divergent Hypoglycemic Effects of Hepatic-Directed Prandial Insulin: A 6-Month Phase 2b Study in Type 1 Diabetes
David Klonoff, Bruce Bode, Nathan Cohen, Marc Penn, W. Blair Geho, Douglas B. Muchmore

Diabetes Care Nov 2019, 42 (11) 2154-2157; DOI: 10.2337/dc19-0152
You have access
Pharmacokinetics, Pharmacodynamics, and Modulation of Hepatic Glucose Production With Insulin Glargine U300 and Glargine U100 at Steady State With Individualized Clinical Doses in Type 1 Diabetes
Francesca Porcellati, Paola Lucidi, Paola Candeloro, Patrizia Cioli, Anna Marinelli Andreoli, Gianluca Curti, Geremia B. Bolli, Carmine G. Fanelli

Diabetes Care Jan 2019, 42 (1) 85-92; DOI: 10.2337/dc18-0706
You have access
Patients With Type 2 Diabetes Are Willing to Do More to Overcome Therapeutic Inertia: Results From a Double-Blind Survey
Steven V. Edelman, Richard Wood, Michelle Roberts, Jay H. Shubrook

Clinical Diabetes Feb 2020, cd190067; DOI: 10.2337/cd19-0067
You have access
Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial
Bruce W. Bode, Violeta Iotova, Margarita Kovarenko, Lori M. Laffel, Paturi V. Rao, Srikanth Deenadayalan, Magnus Ekelund, Steffen Falgreen Larsen, Thomas Danne

Diabetes Care Jul 2019, 42 (7) 1255-1262; DOI: 10.2337/dc19-0009

Main menu

User menu

Search

Clinical Therapeutics/New Technology-Insulins

Pages

Navigate

More Information

Other ADA Resources